Doxorubicin Influences the Expression of Glucosylceramide Synthase in Invasive Ductal Breast Cancer

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Zhang, Xiaofang ^a   Wu, Xiaojuan ^a   Su, Peng ^a   Gao, Yongsheng ^b   Meng, Bin ^a   Sun, Yanlin ^a   Li, Li ^a   Zhou, Zhiqiang ^a   Zhou, Gengyin ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Department of Pathology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE GLUCOSYLTRANSFERASE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR ALPHA; FLUOROURACIL; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE;

ADULT; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER CHEMOTHERAPY; CHEMOSENSITIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENE; GLUCOSYLCERAMIDE SYNTHASE GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PREOPERATIVE TREATMENT; PROTEIN EXPRESSION; UPREGULATION;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; DOXORUBICIN; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSYLTRANSFERASES; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROMOTER REGIONS, GENETIC; RNA, MESSENGER;

EID: 84868305798     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048492     Document Type: Article

References (19)

1. Ozben T, (2006) Mechanisms and strategies to overcome multiple drug resistance in cancer. FEBS Lett 580: 2903-2909.
2. Kaszubiak A, Holm PS, Lage H, (2007) Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes.Int J Oncol. 31: 419-430.
3. Yamashita T, (2000) A vital role for glycosphingolipid synthesis during development and differentiation.Seikagaku. 72: 1420-1425.
4. Gouaze V, Yu JY, Bleicher RJ, Han TY, Liu YY, et al. (2004) Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy. Mol Cancer Ther 3: 633-639.
5. Sun Y, Zhang T, Gao P, Memg B, Gao Y, et al. (2010) Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs. Breast Cancer Res Treat 121: 591-599.
6. Liu YY, Han TY, Giuliano AE, Cabot MC, (1999) Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells. J Biol Chem 274: 1140-1146.
7. Liu YY, Han TY, Giuliano AE, Hansen N, Cabot MC, (2000) Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance. J Biol Chem 275: 7138-7143.
8. Uchida Y, Itoch M, Taguchi Y, Yamaoka S, Umehara H, et al. (2004) Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through doxorubicin-activated Sp1 in drug-resistance HL-60/ADR cells. Cancer Res 64: 6271-6279.
9. Liu YY, Yu JY, Yin D, Patwardhan GA, Gupta V, et al. (2008) A role for ceramide in driving cancer cell resistance to doxorubicin. FASEB J 22: 2541-2551.
10. Zhang X, Li J, Qiu Z, Gao P, Wu X, et al. (2009) Co-suppression of MDR1(multidrug resistance 1) and GCS (glucosylceramide synthase) restores sensitivity to multidrug resistance breast cancer cells by RNA interference(RNAi). Cancer Biol Ther 8: 1117-1121.
11. Ruckhaberle E, Kam T, Hanker L, Gatje R, Metzler D, et al. (2009) Prognostic relevance of glucosylceramide synthase(GCS) expression in breast cancer. J Cancer Res Clin Oncol 135: 81-90.
12. Charn TH, Liu ET, Chang EC, Lee YK, Katzenellenbogen JA, et al. (2010) Genome-wide dynamics of chromatin binding of estrogen receptors alpha and beta: mutual restriction and competitive site selection. Mol Endocrinol 24: 47-59.
13. Ueda K, Cardarelli C, Gottesman MM, Pastan I, (1987) Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA 84: 3004-3008.
14. Hannun YA, Luberto C, Argraves KM, (2001) Enzymes of sphingolipid metabolism: from modular to integrative signaling. Biochemistry 40: 4893-4903.
15. Abe A, Radin NS, Shayman JA, (1996) Indubtion of glucosylceramide synthase by synthase inhibitors and ceramide. Biochim Biophys Acta 1299: 333-341.
16. Uchida Y, Murata S, Schmuth M, Behne MJ, Lee JD, et al. (2002) Glucosylceramide synthasis and synthase expression ptotect against ceramide-induced stress. J Lipid Res 43: 1293-1302.
17. Lidcovitch M, Ravid D, (2007) A case study in mididentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells. Cancer Lett 245: 350-352.
18. Rudas M, Filipits M, Tancher S, Stranzl T, Steger GG, et al. (2003) Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy. Breast Cancer Res Treat 81: 149-157.
19. Liu YY, Patwardhan GA, Xie P, Gu X, Giuliano AE, et al. (2011) Glucosylceramide synthase, a factor in modulating drug resistance, is overexpressed in matastatic breast carcinoma. Int I Oncol 39: 425-431.